REV1 is a Y-family polymerase that plays a central role in mutagenic translesion DNA synthesis (TLS), contributing to tumor initiation and progression. In a current model, a monoubiquitinated form of the replication accessory protein, proliferating cell nuclear antigen (PCNA), serves as a platform to recruit REV1 to damaged sites on the DNA template. Emerging evidence indicates that posttranslational mechanisms regulate REV1 in yeast; however, the regulation of REV1 in higher eukaryotes is poorly understood. Here we show that the molecular chaperone Hsp90 is a critical regulator of REV1 in human cells. Hsp90 specifically binds REV1 in vivo and in vitro. Treatment with a specific inhibitor of Hsp90 reduces REV1 protein levels in several cell types through proteasomal degradation. This is associated with suppression of UV-induced mutagenesis. Furthermore, Hsp90 inhibition disrupts the interaction between REV1 and monoubiquitinated PCNA and suppresses UV-induced focus formation. These results indicate that Hsp90 promotes folding of REV1 into a stable and/or functional form(s) to bind to monoubiquitinated PCNA. The present findings reveal a novel role of Hsp90 in the regulation of TLS-mediated mutagenesis.Genomic DNA is constantly exposed to both extrinsic and intrinsic genotoxic agents, such as UV light and oxidative stress. Although most DNA lesions are removed by multiple DNA repair pathways, some escape these mechanisms and persist in the genome. Such unrepaired DNA lesions usually block the progression of replication forks catalyzed by highfidelity DNA polymerases (Pols), which may lead to downstream reinitiation of DNA synthesis, leaving single-stranded DNA gaps. Translesion synthesis (TLS) is an essential mechanism for bypassing such replication blocks and postreplicative gaps by employing specialized Pols, including Pol , Pol , Pol , and REV1, members of the Y-family Pols (Y-Pols), and Pol , a member of the B family (10,14,28,43,58). These TLS Pols display low stringency for the active site and a lack of proofreading, and thus they contribute to mutagenesis and to DNA damage tolerance. Recruitment of the TLS Pols at sites of DNA damage depends on Rad6/Rad18-and CRL4Cdt2 -mediated production of monoubiquitinated proliferating cell nuclear antigen (PCNA) (Ub-PCNA), to which Y-Pols bind with high affinity (3, 21, 54, 57).REV1 plays a central role in promoting mutagenesis in lower and higher eukaryotes. Of note, the mutagenic activity of REV1 contributes to tumor initiation and progression in mammals (9, 29, 62). REV1 has a unique deoxycytidyl transferase activity in vitro, incorporating dCMP opposite several types of DNA lesions, such as abasic sites and damaged guanines (17,18,30,38,65); however, this enzymatic activity is dispensable for REV1-mediated TLS (37). Instead, the function of REV1 depends on protein-protein interactions via three key domains: the N-terminal BRCT domain (named after the C-terminal domain of a breast cancer susceptibility protein) (15,22,23), ubiquitin (Ub)-binding motifs (UBMs) in th...